Friday, December 1, 2017

Adamis Pharmaceuticals Announces Presentation of Results of a ...

Nasdaq-2 hours ago
The Company's U.S. Compounding, Inc. (USC) subsidiary, which is registered as a drug compoundingoutsourcing facility under Section 503B of the U.S. Food, Drug & Cosmetic Act and the U.S. Drug Quality and Security Act, compounds sterile prescription drugs, and certain nonsterile drugs, to patients, physician clinics, ...
Post a Comment